Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Nasal IgE Production in Birch Pollen Allergy
NCT05042830Recruiting
- Sponsor
- Medical University of Vienna
- Start
- Nov 2021
- Primary completion
- Jan 2026
- Modality
- Biologic
- Countries
- 1
01
Overview
Randomised, double-blind trial of birch pollen extract in allergic rhinitis (AR) (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Quantification of IgE producing cells at 3 years. Started Nov 2021; status: recruiting.
02
Drugs
birch pollen extract
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT05042830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05042830.